Pharmeca.cz

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

Notification  of the Ministry of Health of the Czech Republic,  against the decision of the State Institute for Drug Control from 13. 8. 2018, under the no. SUKLS298807/2018, regarding the withdrawal of the appeal of the appelant Roche Registration GmbH. The decision of the State Institute for Drug Control is valid since 3. 3. 2020.

More information: MZCR.cz (czech version only)

 

Notification  of the Ministry of Health of the Czech Republic,  against the decision of the State Institute for Drug Control from 21. 6. 2019, under the no. SUKLS21000/2019, regarding the withdrawal of the appeal of the appelant PRO.MED.CS Praha a.s. The decision of the State Institute for Drug Control is valid since 10. 1. 2020. 

More information: MZCR.cz (czech version only)

 

This note presents selected findings based on the set of well-being indicators published in How's Life? 2020.

 

Více na: OECD.org - Czech Republic

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 15. 5. 2017, under the no. SUKLS44039/2017 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant SANOFI-AVENTIS DEUTSCHLAND GMBH, against the decision of the State Institute for Drug Control from 19. 9. 2017, under the no. sukls244621/2016 - Under article 90 paragraph 1 letter b) of the Administration Code the operative part 1 and 2 of the decision under appeal is dismissed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 20. 11. 2019, under the no. SUKLS401789/2017 - The appeal is dismissed and the decision under appeal is upheld

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 5. 11. 2019, under the no. SUKLS141283/2018 - 

The appeal is dismissed and the decision under appeal is upheld.

More information:  MZCR.cz (czech version only)